Active, not recruitingNCT03193801
PARTNER 3 Trial - Mitral Valve in Valve
AI Description
To assess the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with a failing mitral bioprosthetic valve.
- Who can join
- child, adult, older adult
- Participants
- 53
- Expected completion
- 2031-08
- Funded by
- industry
Conditions studied
Heart Failure, Mitral Valve Disease, Mitral Valve Insufficiency, Mitral Valve Regurgitation
What is being tested
- DEVICE: Edwards SAPIEN 3 transcatheter valve, Model 9600TFX
What it measures
- Safety and Effectiveness - Composite of All-cause Mortality and Stroke, Non-hierarchical composite endpoint of all-cause mortality and stroke at 1-year post-procedure, 1 Year
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Barnes-Jewish Hospital
Saint Louis, MO
Baylor Scott & White The Heart Hospital – Plano
Plano, TX
Brigham and Women's Hospital
Boston, MA
Emory University Hospital
Atlanta, GA
Endeavor Health Evanston Hospital
Evanston, IL
Mayo Clinic (Rochester, Minnesota)
Rochester, MN
Northwestern Memorial Hospital
Chicago, IL
NYU Langone Health
New York, NY
Providence St. Vincent Medical Center
Portland, OR
Registry entry updated 2025-11-05
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.